These agents include thiazolidinediones (PPAR- agonists), dipeptidyl peptidase-4 (DPP-4) inhibitors, sulfonylureas, sodium-glucose co-transporter 2 (SGLT2) inhibitors, -glucosidase inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists
Patients eligible to enter the trial were
In a six-week randomized controlled trial on 24 diabetic participants, supplementation with 500 mg of hesperidin per day improved glycemic control, increased total antioxidant capacity, and reduced oxidative stress and DNA injury (Homayouni 2017)
The foundations that support dopamine precursor synthesis include: Vitamin D maintained at approximately 50 ng/mL Magnesium glycinate 400 mg before bed Methylated B complex daily These support the raw materials the central nervous system uses to produce neurotransmitters
A new class of glucose-lowering therapy for type 2 diabetes: the latest development in the incretin arena